G9778 – Patients who have a diagnosis of pregnancy at any time during the measurement period
HCPCS Level II code · G codes: Procedures / Professional Services (Temporary)
HCPCS codeG9778
- Long description
- Patients who have a diagnosis of pregnancy at any time during the measurement period
- Short description
- Pts dx w/pregn
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
Z2Undefined codes- Added
- January 1, 2017
- Last change
- January 1, 2023 – No change
- Termination date
- December 31, 2022
Frequently asked questions
What is HCPCS code G9778?
G9778 is a HCPCS Level II code for patients who have a diagnosis of pregnancy at any time during the measurement period. It was discontinued on December 31, 2022.
Does Medicare cover G9778?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby G codes
- G9770 – Peripheral nerve block (pnb)
- G9771 – At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time
- G9772 – Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)
- G9773 – At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time, reason not given
- G9774 – Patients who have had a hysterectomy
- G9775 – Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
- G9776 – Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)
- G9777 – Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
- G9779 – Patients who are breastfeeding at any time during the performance period
- G9780 – Patients who have a diagnosis of rhabdomyolysis at any time during the performance period
- G9781 – Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)
- G9782 – History of or active diagnosis of familial hypercholesterolemia
- G9783 – Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy
- G9784 – Pathologists/dermatopathologists providing a second opinion on a biopsy
- G9785 – Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
- G9786 – Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.